Noom releases a significant update of its innovative GLP-1 companion to improve medication persistence and adherence while decreasing side effect ...

Noom releases a significant update of its innovative GLP-1 companion to improve medication persistence and adherence while decreasing side effect prevalence and improving lean mass preservation and ...

The European Union has a plan for dealing with increasing cyberattacks against hospitals in its member countries.

Noom is best known for its eponymous app that helps people become healthier and lose weight by making changes to their diet and behaviours, and executive chair and former CEO Saeju Jeong said the ...

Noom is offering a January sale of sorts. Using the code NEWYEAR6 with the purchase of a Noom Weight subscription will give you a 12-month plan for the price of a standard 6-month plan.

Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight ...

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide ...

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...

Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, ...